Inno Medicine Moves Novel Liposome Into Pivotal Trial For Coronary Plaque

 
• By Dexter Jie Yan
  
Inno Medicine's YN001 will directly tackle coronary atherosclerosis plaques with regression potential. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from Leadership